These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 16690312)

  • 21. Syntheses and structure-activity relationship studies of piperidine-substituted quinolones as nonpeptide gonadotropin releasing hormone antagonists.
    Jiang J; DeVita RJ; Goulet MT; Wyvratt MJ; Lo JL; Ren N; Yudkovitz JB; Cui J; Yang YT; Cheng K; Rohrer SP
    Bioorg Med Chem Lett; 2004 Apr; 14(7):1795-8. PubMed ID: 15026074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of 1,3-disubstituted-1H-pyrrole derivatives as potent melanin-concentrating hormone receptor 1 (MCH-R1) antagonists.
    Berglund S; Egner BJ; Gradén H; Gradén J; Morgan DG; Inghardt T; Giordanetto F
    Bioorg Med Chem Lett; 2008 Sep; 18(17):4859-63. PubMed ID: 18682323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CCR5 antagonists as anti-HIV-1 agents. Part 3: Synthesis and biological evaluation of piperidine-4-carboxamide derivatives.
    Imamura S; Nishikawa Y; Ichikawa T; Hattori T; Matsushita Y; Hashiguchi S; Kanzaki N; Iizawa Y; Baba M; Sugihara Y
    Bioorg Med Chem; 2005 Jan; 13(2):397-416. PubMed ID: 15598561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 6-Acylamino-2-amino-4-methylquinolines as potent melanin-concentrating hormone 1 receptor antagonists: structure-activity exploration of eastern and western parts.
    Ulven T; Little PB; Receveur JM; Frimurer TM; Rist O; Nørregaard PK; Högberg T
    Bioorg Med Chem Lett; 2006 Feb; 16(4):1070-5. PubMed ID: 16289819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel class of sodium/calcium exchanger inhibitors: design, synthesis, and structure-activity relationships of 4-phenyl-3-(piperidin-4-yl)-3,4-dihydro-2(1H)-quinazolinone derivatives.
    Hasegawa H; Muraoka M; Matsui K; Kojima A
    Bioorg Med Chem Lett; 2006 Feb; 16(3):727-30. PubMed ID: 16249082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of piperidine-aryl urea-based stearoyl-CoA desaturase 1 inhibitors.
    Xin Z; Zhao H; Serby MD; Liu B; Liu M; Szczepankiewicz BG; Nelson LT; Smith HT; Suhar TS; Janis RS; Cao N; Camp HS; Collins CA; Sham HL; Surowy TK; Liu G
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4298-302. PubMed ID: 18632269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and synthesis of 4-phenyl piperidine compounds targeting the mu receptor.
    Chen Z; Davies E; Miller WS; Shan S; Valenzano KJ; Kyle DJ
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5275-9. PubMed ID: 15454210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimization of 2-piperidin-4-yl-acetamides as melanin-concentrating hormone receptor 1 (MCH-R1) antagonists: Designing out hERG inhibition.
    Berglund S; Egner BJ; Gradén H; Gradén J; Morgan DG; Inghardt T; Giordanetto F
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4268-73. PubMed ID: 19500979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 4-arylphthalazin-1(2H)-one derivatives as potent antagonists of the melanin concentrating hormone receptor 1 (MCH-R1).
    Lim CJ; Kim SH; Lee BH; Oh KS; Yi KY
    Bioorg Med Chem Lett; 2012 Jan; 22(1):427-30. PubMed ID: 22137790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bis(aminopyrrolidine)-derived ureas (APUs) as potent MCH1 receptor antagonists.
    Grey J; Dyck B; Rowbottom MW; Tamiya J; Vickers TD; Zhang M; Zhao L; Heise CE; Schwarz D; Saunders J; Goodfellow VS
    Bioorg Med Chem Lett; 2005 Feb; 15(4):999-1004. PubMed ID: 15686900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and optimization of quinazoline derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists: part 2.
    Sasmal S; Balasubrahmanyam D; Kanna Reddy HR; Balaji G; Srinivas G; Cheera S; Abbineni C; Sasmal PK; Khanna I; Sebastian VJ; Jadhav VP; Singh MP; Talwar R; Suresh J; Shashikumar D; Harinder Reddy K; Sihorkar V; Frimurer TM; Rist Ø; Elster L; Högberg T
    Bioorg Med Chem Lett; 2012 May; 22(9):3163-7. PubMed ID: 22497763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of melanin-concentrating hormone receptor and its impact on drug discovery.
    Saito Y; Maruyama K
    J Exp Zool A Comp Exp Biol; 2006 Sep; 305(9):761-8. PubMed ID: 16902961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of a novel series of melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity.
    Mihalic JT; Chen X; Fan P; Chen X; Fu Y; Liang L; Reed M; Tang L; Chen JL; Jaen J; Li L; Dai K
    Bioorg Med Chem Lett; 2011 Dec; 21(23):7001-5. PubMed ID: 22019296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pyrazolone methylamino piperidine derivatives as novel CCR3 antagonists.
    Pégurier C; Collart P; Danhaive P; Defays S; Gillard M; Gilson F; Kogej T; Pasau P; Van Houtvin N; Van Thuyne M; van Keulen B
    Bioorg Med Chem Lett; 2007 Aug; 17(15):4228-31. PubMed ID: 17532633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and evaluation of 3-aryl piperidine analogs as potent and efficacious dopamine D4 receptor agonists.
    Wang X; Bhatia PA; Daanen JF; Latsaw SP; Rohde J; Kolasa T; Hakeem AA; Matulenko MA; Nakane M; Uchic ME; Miller LN; Chang R; Moreland RB; Brioni JD; Stewart AO
    Bioorg Med Chem; 2005 Aug; 13(15):4667-78. PubMed ID: 15896964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel histamine H3 receptor antagonists based on the 4-[(1H-imidazol-4-yl)methyl]piperidine scaffold.
    Vaccaro WD; Sher R; Berlin M; Shih NY; Aslanian R; Schwerdt JH; McCormick KD; Piwinski JJ; West RE; Anthes JC; Williams SM; Wu RL; She HS; Rivelli MA; Mutter JC; Corboz MR; Hey JA; Favreau L
    Bioorg Med Chem Lett; 2006 Jan; 16(2):395-9. PubMed ID: 16246552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The synthesis and structure-activity relationship of 4-benzimidazolyl-piperidinylcarbonyl-piperidine analogs as histamine H3 antagonists.
    Ting PC; Lee JF; Albanese MM; Wu J; Aslanian R; Favreau L; Nardo C; Korfmacher WA; West RE; Williams SM; Anthes JC; Rivelli MA; Corboz MR; Hey JA
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5004-8. PubMed ID: 20685118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Piperidine-containing beta-arylpropionic acids as potent antagonists of alphavbeta3/alphavbeta5 integrins.
    De Corte BL; Kinney WA; Liu L; Ghosh S; Brunner L; Hoekstra WJ; Santulli RJ; Tuman RW; Baker J; Burns C; Proost JC; Tounge BA; Damiano BP; Maryanoff BE; Johnson DL; Galemmo RA
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5227-32. PubMed ID: 15380233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elucidation of the bioactive conformation of the N-substituted trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine class of mu-opioid receptor antagonists.
    Le Bourdonnec B; Goodman AJ; Michaut M; Ye HF; Graczyk TM; Belanger S; Herbertz T; Yap GP; DeHaven RN; Dolle RE
    J Med Chem; 2006 Dec; 49(25):7278-89. PubMed ID: 17149858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melanocortin subtype 4 receptor agonists: structure-activity relationships about the 4-alkyl piperidine core.
    Sebhat IK; Lai Y; Barakat K; Ye Z; Tang R; Kalyani RN; Vongs A; Macneil T; Weinberg DH; Cabello MA; Maroto M; Teran A; Fong TM; Van der Ploeg LH; Patchett AA; Nargund RP
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5720-3. PubMed ID: 17768046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.